Pretargeted radioimmunotherapy of cancer: progress step by step.
about
Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistryPre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinomaDevelopment of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results.A modular IgG-scFv bispecific antibody topology.Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibodyComparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studies.Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imagingPretargeted radioimmunotherapy for hematologic and other malignanciesPAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approachSystemic radiotherapy can cure lymphoma: a paradigm for other malignancies?The potential and hurdles of targeted alpha therapy - clinical trials and beyond.Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy.Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinomaFurther investigations of morpholino pretargeting in mice--establishing quantitative relations in tumorSuccessful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting.Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.An improved synthesis of arsenic-biotin conjugates.Radiolabeled antibodies in renal cell carcinoma.A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.A semiempirical model of tumor pretargeting.Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.Biodistribution and clearance of small molecule hapten chelates for pretargeted radioimmunotherapy.The inverse electron demand Diels-Alder click reaction in radiochemistry.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.(99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.MR signal amplification for imaging of the mutant EGF receptor in orthotopic human glioma model.A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.A33 antigen displays persistent surface expression.Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.
P2860
Q27026010-3F5E0AD8-32B7-4FA0-AFDF-5211E3BD171AQ28481572-B9A8C5EB-0188-4004-8D84-A6CDCA130866Q33409137-C592F998-5188-4815-9E43-811E832E1BAEQ33519465-B8FED17B-7B9D-4818-AD90-23C6D30562D0Q33649168-A6ABD2D3-A4E5-41F7-88F1-A843F775DB4AQ33775752-1D4E3ED1-C287-4A99-9696-C08D7F68ACECQ33780787-676A813C-2545-4654-83B1-BEBC49575F8EQ33877207-9FA4D917-BA3F-4FCC-ACA5-DBCDAFD10B04Q33921086-CF2E458D-FC51-4EC9-A438-35173CE94A53Q34113941-3DDE6FB7-067F-4B9B-8AD7-69BE150D3712Q34165944-929B4421-19AF-4FB4-8351-726BFF93395AQ34335207-FDF468B3-A2CE-4254-98C7-1248194D63B1Q34399879-F21DDE2F-A2D1-494B-BA7B-CAA380C4F2D8Q34731015-9641E411-0455-4816-B3A6-F62A6F162226Q35059542-8EB272D2-57EF-4E73-91A5-C1C6C1B2703DQ35063676-78BC310A-54E8-4248-A3FB-B659A3648D31Q35063681-17B56446-444C-4793-B4BC-BE3C4A83E870Q35162177-A3128EBE-5520-49A5-A5F5-F6BA7F530985Q35801347-44DECF0E-E887-4328-A1D7-B2C17C4FF0B4Q35819169-1E22D0D6-33B3-4446-BF02-78765979C1BAQ35880923-C053585C-B7F3-4126-895C-D1E51E1C0D5AQ36082355-0E155E98-D7F2-44E8-9754-7B89417FBF8AQ36088136-A4B02619-8DCA-49CC-B949-EECF72F9B13DQ36418274-8666FB7A-F9A9-4F6A-A881-C93037E00C30Q36690711-E5F13B58-B93E-438D-994D-A31CD05E338DQ36775811-2DC3CD0F-0B4A-4095-AA63-B31819FE2F6EQ37022628-375A1A2C-72D0-4FE7-AB52-DD8CFFAC2473Q37201878-5037682B-8A4B-4393-8404-DFDEEB246AEBQ37207310-8EF8F380-04CD-44E5-AD49-1C75E0F6E67CQ37288717-340C5783-4357-4302-B126-85045DC7343EQ37403530-7180ED15-4F1D-444B-925E-B9CE19F24DA2Q37656465-D157373E-09C9-479F-9BA3-3FFFE93527A6Q38172061-4A6F4E3E-D308-4503-B883-A7D8BF1CEE4AQ38206206-53ADAEB9-D1F1-4559-AA1E-AD1FD5BF0FFBQ38794260-DD2221CB-8296-45FF-8453-DA9AAA049E2BQ39144294-6CA6D046-7137-4043-80CC-6F0F277F5D7AQ39147376-23BA4EF0-241C-4A16-8599-757923DFF3D0Q39543140-FEECBB2D-1938-45B4-A237-D645D70146A1Q39753915-ECC49E70-9E49-45FD-8DBB-EA3FE94EE625Q39805119-6EB39511-95F0-4B18-B6B1-688AE954C6AB
P2860
Pretargeted radioimmunotherapy of cancer: progress step by step.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pretargeted radioimmunotherapy of cancer: progress step by step.
@ast
Pretargeted radioimmunotherapy of cancer: progress step by step.
@en
type
label
Pretargeted radioimmunotherapy of cancer: progress step by step.
@ast
Pretargeted radioimmunotherapy of cancer: progress step by step.
@en
prefLabel
Pretargeted radioimmunotherapy of cancer: progress step by step.
@ast
Pretargeted radioimmunotherapy of cancer: progress step by step.
@en
P2093
P1476
Pretargeted radioimmunotherapy of cancer: progress step by step.
@en
P2093
Frank G van Schaijk
Frans H M Corstens
Wim J G Oyen
P304
P407
P577
2003-03-01T00:00:00Z